Journals / Turkish Journal of Anaesthesiology and Reanimation / 2022 / Cilt: 50 - Sayı: 1

Fatal Community-Acquired Peritonitis Due to Invasive Necrotizing Intestinal Mucormycosis: Case Report and Review of the Literature

Pages
65–67
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Diagnosis was established by direct examination of peritoneal fluid showing hyphae consistent with mucormycosis confirmed by the culture.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We report here a rare case of fatal rapidly progressive necrotizing gastrointestinal mucormycosis due to Mucor circinelloides f. circinelloides in the setting of community-acquired peritonitis, in an immunocompromised adult patient.
📊
Key Findings & Data:We report here a rare case of fatal rapidly progressive necrotizing gastrointestinal mucormycosis due to Mucor circinelloides f. circinelloides in the setting of community-acquired peritonitis, in an immunocompromised adult patient.
💡
Conclusion & Impact:Diagnosis was established by direct examination of peritoneal fluid showing hyphae consistent with mucormycosis confirmed by the culture.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

We report here a rare case of fatal rapidly progressive necrotizing gastrointestinal mucormycosis due to Mucor circinelloides f. circinelloides in the setting of community-acquired peritonitis, in an immunocompromised adult patient. Diagnosis was established by direct examination of peritoneal fluid showing hyphae consistent with mucormycosis confirmed by the culture.

🔖

Cite This Article

VASSAL, O., DUPONT, D., ADER, F., WALLET, F., DAVIGO, A., PASSOT, G., PERSAT, F., ALLAOUCHICHE, B. (2022). Fatal Community-Acquired Peritonitis Due to Invasive Necrotizing Intestinal Mucormycosis: Case Report and Review of the Literature. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 50 - Sayı: 1, 65–67. https://ajindex.com/articles/418114

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis. 2005
  2. [CrossRef] 2. Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: The RetroZygo study (2005-2007). Clin Infect Dis. 2012
  3. S35-S43. [CrossRef] 3. Kaur H, Ghosh A, Rudramurthy SM, Chakrabarti A. Gastrointestinal mucormycosis in apparently immunocompetent hosts—A review. Mycoses. 2018
  4. [Cross- Ref] 4. Nayak S, Satish R, Gokulnath Savio J, Rajalakshmi T. Peritoneal mucormycosis in a patient on CAPD. Perit Dial Int. 2007
  5. [CrossRef] 5. Hyvernat H, Dunais B, Burel-Vandenbos F, Guidicelli S, Bernardin G, Gari-Toussaint M. Fatal peritonitis caused by Rhizopus microsporus. Med Mycol. 2010
  6. [CrossRef] 6. Termos S, Othman F, Alali M, et al. Total gastric necrosis due to mucormycosis: A rare case of gastric perforation. Am J Case Rep. 2018
  7. [CrossRef] 7. Millon L, Herbrecht R, Grenouillet F, et al. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: Retrospective analysis of 44 cases collected through the French surveillance network of invasive fungal infections (RESSIF). Clin Microbiol Infect. 2016
  8. e1–810.e8. [CrossRef] 8. Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: An initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium. Lancet Infect Dis. 2019
  9. E405-E421. [CrossRef] 9. Ibrahim AS, Gebremariam T, Fu Y, Edwards JE, Spellberg B. Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrob Agents Chemother. 2008
  10. [CrossRef] 10. Ojeda-Uribe M, Herbrecht R, Kiefer MH, et al. Lessons from a case of oromandibular mucormycosis treated with surgery and a combination of amphotericin B lipid formulation plus caspofungin. Acta Haematol. 2010
  11. [CrossRef] 11. Kazak E, Aslan E, Akalın H, et al. A mucormycosis case treated with a combination of caspofungin and amphotericin B. J Mycol Me´d. 2013
  12. [CrossRef] 12. Tissot F, Agrawal S, Pagano L, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 2017
  13. [CrossRef] 13. Marty FMO, Zeichner L, Cornely OA, et al. Isavuconaz